Valter Monteiro

Dr. Valter Monteiro

Microbial Pathogenesis, Yale University, New Haven, Connecticut, USA
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 September 2023 in Nature
Verified
Journal Article
Open access
PDF file
JKJon Klein
Jon Klein
JWJamie Wood
Jamie Wood
JJJillian R. Jaycox
Jillian R. Jaycox
RDRahul M. Dhodapkar
Rahul M. Dhodapkar
PLPeiwen Lu
Peiwen Lu
AIAkiko Iwasaki
Akiko Iwasaki
Post-acute infection syndromes may develop after acute viral disease1. Infection with SARS-CoV-2 can result in the development of a post-acute infection syndrome known as long COVID. Individuals with long COVID frequently report unremitting fatigue, post-exertional malaise, and a variety of cognitive and autonomic dysfunctions2–4. However, the biological processes that are associated with the development and persistence of these symptoms are unclear. Here 275 individuals with or without long COVID were enrolled in a cross-sectional study that included multidimensional immune phenotyping and unbiased machine learning methods to identify biological features associated with long COVID. Marked differences were noted in circulating myeloid and lymphocyte populations relative to the matched controls, as well as evidence of exaggerated humoral responses directed against SARS-CoV-2 among participants with long COVID. Furthermore, higher antibody responses directed against non-SARS-CoV-2 viral pathogens were observed among individuals with long COVID, particularly Epstein–Barr virus. Levels of soluble immune mediators and hormones varied among groups, with cortisol levels being lower among participants with long COVID. Integration of immune phenotyping data into unbiased machine learning models identified the key features that are most strongly associated with long COVID status. Collectively, these findings may help to guide future studies into the pathobiology of long COVID and help with developing relevant biomarkers.

20 January 2022 in Nature Medicine
Verified
Journal Article
Open access
PDF file
EPEddy Pérez-Then
Eddy Pérez-Then
CLCarolina Lucas
Carolina Lucas
VMValter Monteiro
Valter Monteiro
MMMarija Miric
Marija Miric
VBVivian Brache
Vivian Brache
AIAkiko Iwasaki
Akiko Iwasaki
The recent emergence of the SARS-CoV-2 Omicron variant is raising concerns because of its increased transmissibility and its numerous spike mutations, which have the potential to evade neutralizing antibodies elicited by COVID-19 vaccines. Here we evaluated the effects of a heterologous BNT162b2 mRNA vaccine booster on the humoral immunity of participants who had received a two-dose regimen of CoronaVac, an inactivated vaccine used globally. We found that a heterologous CoronaVac prime vaccination of two doses followed by a BNT162b2 booster induces elevated virus-specific antibody levels and potent neutralization activity against the ancestral virus and the Delta variant, resembling the titers obtained after two doses of mRNA vaccines. Although neutralization of Omicron was undetectable in participants who had received a two-dose regimen of CoronaVac, the BNT162b2 booster resulted in a 1.4-fold increase in neutralization activity against Omicron compared with the two-dose mRNA vaccine. Despite this increase, neutralizing antibody titers were reduced by 7.1-fold and 3.6-fold for Omicron compared with the ancestral strain and the Delta variant, respectively. These findings have immediate implications for multiple countries that previously used a CoronaVac regimen and reinforce the idea that the Omicron variant is associated with immune escape from vaccines or infection-induced immunity, highlighting the global need for vaccine boosters to combat the impact of emerging variants.

23 December 2021 in Blood
Verified
Journal Article
Closed access
PDF file
CSCamila Meirelles S. Silva
Camila Meirelles S. Silva
CWCarlos Wagner S. Wanderley
Carlos Wagner S. Wanderley
FVFlavio P. Veras
Flavio P. Veras
FSFabiane Sonego
Fabiane Sonego
DNDaniele Carvalho Nascimento
Daniele Carvalho Nascimento
FCFernando Q. Cunha
Fernando Q. Cunha
Multiple organ dysfunction is the most severe outcome of sepsis progression and is highly correlated with a worse prognosis. Excessive neutrophil extracellular traps (NETs) are critical players in the development of organ failure during sepsis. Therefore, interventions targeting NET release would likely effectively prevent NET-based organ injury associated with this disease. Herein, we demonstrate that the pore-forming protein gasdermin D (GSDMD) is active in neutrophils from septic humans and mice and plays a crucial role in NET release. Inhibition of GSDMD with disulfiram or genic deletion abrogated NET formation, reducing multiple organ dysfunction and sepsis lethality. Mechanistically, we demonstrate that during sepsis, activation of the caspase-11/GSDMD pathway controls NET release by neutrophils during sepsis. In summary, our findings uncover a novel therapeutic use for disulfiram and suggest that GSDMD is a therapeutic target to improve sepsis treatment.

15 November 2016 in Journal of Translational Medicine
Verified
Journal Article
Open access
PDF file
JRJordano Ferreira Reis
Jordano Ferreira Reis
VMValter Monteiro
Valter Monteiro
RGRafaelli de Souza Gomes
Rafaelli de Souza Gomes
MCMatheus Moraes Do Carmo
Matheus Moraes Do Carmo
GCGlauber Costa
Glauber Costa
MMMarta Monteiro
Marta Monteiro
Cardiovascular diseases (CVD) are an important cause of death worldwide. Anthocyanins are a subgroup of flavonoids found in berries, flowers, fruits and leaves. In epidemiological and clinical studies, these polyphenols have been associated with improved cardiovascular risk profiles as well as decreased comorbidities. Human intervention studies using berries, vegetables, parts of plants and cereals (either fresh or as juice) or purified anthocyanin-rich extracts have demonstrated significant improvements in low density lipoproteins oxidation, lipid peroxidation, total plasma antioxidant capacity, and dyslipidemia as well as reduced levels of CVD molecular biomarkers. This review discusses the use of anthocyanins in animal models and their applications in human medicine, as dietary supplements or as new potent drugs against cardiovascular disease.

24 January 2019 in Current Pharmaceutical Design
Verified
Journal Article
Closed access
PDF file
JSJoão P.B. Silva
João P.B. Silva
KNKely C. Navegantes-Lima
Kely C. Navegantes-Lima
AOAna L.B. Oliveira
Ana L.B. Oliveira
DRDávila V.S. Rodrigues
Dávila V.S. Rodrigues
SGSílvia L.F. Gaspar
Sílvia L.F. Gaspar
MMMarta Monteiro
Marta Monteiro
Inflammatory bowel disease (IBD) is a multifactorial chronic disease, commonly associated with alteration in the composition and function of gut microbiota. This process can lead to a decreased production of short chain fatty acids (SCFAs) by the gut microbiota, mainly butyrate, which is an important immunomodulatory molecule in the intestine. Butyrogenic bacteria normally produces butyrate through carbohydrate fermentation or amino acids degradation pathways. This molecule plays an important protective role in intestinal homeostasis acting in both adaptive immunity and innate immunity. This review summarizes the current knowledge about the role of butyrate on the development of IBD and the protective mechanisms of this metabolite on the intestinal mucosa and the whole body, as reported by in vitro and in vivo studies. Thus, butyrate can regulate the activation of regulatory T cells, increasing the acetylation of histones and decreasing the activation of NF-κB. In addition, it can also stimulate the mucus production from epithelial cells and the rearrangement of tight junction proteins.

1 December 2017 in Nutrients
Verified
Journal Article
Open access
PDF file
AOAna Lígia de Oliveira
Ana Lígia de Oliveira
VMValter Monteiro
Valter Monteiro
KLKELY LIMA
KELY LIMA
JRJordano Ferreira Reis
Jordano Ferreira Reis
RGRafaelli De Souza Gomes
Rafaelli De Souza Gomes
MMMarta Monteiro
Marta Monteiro
Autoimmune diseases are still considered to be pressing concerns due the fact that they are leaders in death and disability causes worldwide. Resveratrol is a polyphenol derived from a variety of foods and beverages, including red grapes and red wine. Anti-inflammatory, antioxidant, and antiaging properties of resveratrol have been reported, and in some animal and human studies this compound reduced and ameliorated the progression of autoimmune diseases, such as rheumatoid arthritis, systemic lupus erythematosus, psoriasis, inflammatory bowel disease, and type 1 diabetes mellitus. Thus, this review aims to summarize and critically analyze the role of resveratrol in the modulation of several organ-specific or systemic autoimmune diseases.